Showing results (11-20 of 93) with videos related to
Sort By:
Pageof 10
Pharmacoeconomics|January 26, 2007
Acute/subacute herpes zoster: healthcare resource utilisation and costs in a group of US health plansRalph P Insinga, Robbin F Itzler, James M PellissierEpidemiologic Reviews|June 3, 2006
Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and diseaseErik J Dasbach, Elamin H Elbasha, Ralph P InsingaExpert Review of Vaccines|September 5, 2008
Structural differences among cost-effectiveness models of human papillomavirus vaccinesRalph P Insinga, Erik J Dasbach, Elamin H ElbashaBMC Infectious Diseases|July 31, 2009
Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission modelRalph P Insinga, Erik J Dasbach, Elamin H ElbashaBulletin of Mathematical Biology|October 9, 2008
A multi-type HPV transmission modelElamin H Elbasha, Erik J Dasbach, Ralph P InsingaPharmacoeconomics|November 10, 2005
Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literatureRalph P Insinga, Erik J Dasbach, Elamin H ElbashaThe Journal of Pediatrics|October 16, 2002
Newborn screening with tandem mass spectrometry: examining its cost-effectiveness in the Wisconsin Newborn Screening PanelRalph P Insinga, Ronald H Laessig, Gary L HoffmanBMC Anesthesiology|November 18, 2016
A discrete event simulation model of clinical and operating room efficiency outcomes of sugammadex versus neostigmine for neuromuscular block reversal in CanadaRalph P Insinga, Cédric Joyal, Alexandra Goyette, et al.Cancer|November 2, 2002
Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative womenPhilip E Castle, Sholom Wacholder, Mark E Sherman, et al.Journal of the National Cancer Institute|July 21, 2005
The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practiceMichelle J Khan, Philip E Castle, Attila T Lorincz, et al.Pageof 10